- Home
- Products
Gavreto (Pralsetinib)
Gavreto (Pralsetinib)
- Medicine Name: Gavreto
- Generic Name: Pralsetinib
- Dosage Form & Strength: Capsules – 100 mg
- Manufactured By: Genentech, Inc.
Gavreto is a selective RET kinase inhibitor approved for the treatment of:
- Adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC)
Recommended Dosage
- 400 mg once daily, taken orally on an empty stomach
(No food for at least 2 hours before and 1 hour after) - Continue treatment until disease progression or unacceptable toxicity
✅ If a dose is missed: take it the same day as soon as remembered.
❌ If vomiting occurs: do not retake; continue with the next scheduled dose.
Interstitial Lung Disease (ILD)/Pneumonitis: Withhold for Grade 1/2 and resume at a reduced dose; discontinue permanently for recurrence.
Hypertension: Optimize blood pressure before starting Gavreto. Monitor weekly during the first month, then monthly.
Hepatotoxicity: Monitor ALT/AST before starting, every 2 weeks for 3 months, then monthly.
Bleeding Risk: Discontinue permanently if severe or life-threatening hemorrhage occurs.
Surgical Considerations: Withhold at least 5 days before surgery; avoid for 14 days post-surgery or until wound heals.
Pregnancy: May cause fetal harm. Advise non-hormonal contraception during treatment and for 1 week after the last dose.
Required Documents for Import to India
- Valid prescription from a licensed oncologist
- Diagnostic reports indicating RET fusion-positive NSCLC
- Government-issued Photo ID
Order Confirmation
Confirmed upon:
- Receipt of complete documentation
- Import permit, if required
Availability
Gavreto (Pralsetinib) is available in:
India: Mumbai, Delhi, Noida, Gurgaon, Kolkata, Ahmedabad, Chennai, Hyderabad, Bangalore, Pune, Lucknow, Jaipur, Chandigarh, Ludhiana, Srinagar, Jammu
Worldwide: Also available for export under the Named Patient Program
📞 To Enquire Price or Place Order:
- Phone/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
- Sourced from certified suppliers in the USA, Canada, Europe, and Australia
- Every order is validated by licensed pharmacists
- Dispatched securely from our fulfillment center in Ambernath, Thane District
- Compliant with WHO-GDP and ISO 9001:2008 standards for safety and quality
What is Gavreto used for?
Gavreto treats RET fusion-positive NSCLC and other RET-altered cancers (pending indications in thyroid cancer).
How is Gavreto taken?
Once daily, 400 mg on an empty stomach — no food 2 hours before and 1 hour after.
What is the dosage form?
100 mg oral capsules
Is Gavreto FDA approved?
Yes. FDA approval date: December 1, 2020
Common side effects?
Fatigue, constipation, high blood pressure, musculoskeletal pain
What’s the price of Gavreto in India?
Call or WhatsApp +91-99675 15602 or email info@globalraremeds.com for current pricing
Storage Instructions:
Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C. Keep in original packaging, protected from moisture.
Where can I buy Gavreto legally online?
Yes. Order only via certified distributors like Global Rare Meds – WHO-GDP & ISO approved
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
